Relatório global de análise do tamanho, quota e tendências do mercado farmacêutico de proteína de ovo – Visão geral do setor e previsão para 2031

Proteína de ovo em análise e dimensão do mercado farmacêutico

O mercado farmacêutico da proteína de ovo está a registar um crescimento significativo devido às suas propriedades funcionais únicas e ao seu elevado valor nutricional. Este mercado beneficia da crescente procura de fontes proteicas de elevada qualidade em formulações de medicamentos e produtos biológicos . A capacidade da proteína do ovo de atuar como um estabilizador, emulsionante e transportador eficaz aumenta a solubilidade e a biodisponibilidade dos compostos farmacêuticos, impulsionando a sua adoção. Além disso, a utilização da proteína do ovo na produção de vacinas, especialmente para a gripe e outras vacinas virais, apoia ainda mais a expansão do mercado. Fatores como o aumento dos gastos em saúde, os avanços nas tecnologias farmacêuticas e o crescente foco em sistemas de distribuição de medicamentos eficazes contribuem para a trajetória positiva do mercado.   

Proteína de ovo no tamanho do mercado farmacêutico

O tamanho global do mercado de proteína de ovo em produtos farmacêuticos foi avaliado em 3,66 mil milhões de dólares em 2023 e deverá atingir 6,06 mil milhões de dólares até 2031, com um CAGR de 6,50% durante o período de previsão de 2024 a 2031. Além dos insights sobre cenários de mercado como como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, produção e capacidade da empresa representada geograficamente, layouts de rede de distribuidores e parceiros, análise detalhada e atualizada das tendências de preços e análise do défice da cadeia de abastecimento e da procura.

Âmbito do relatório e segmentação de mercado       

Proteína de ovo na definição do mercado farmacêutico

A proteína do ovo em produtos farmacêuticos refere-se à utilização de proteínas derivadas do ovo, principalmente a clara de ovo, no desenvolvimento e formulação de produtos farmacêuticos. As proteínas do ovo, conhecidas pelo seu elevado valor biológico e pelo seu rico perfil de aminoácidos, são utilizadas pelas suas propriedades funcionais e nutricionais. Na indústria farmacêutica, as proteínas do ovo são frequentemente utilizadas como estabilizantes, emulsionantes e transportadores em formulações de medicamentos. A sua capacidade de aumentar a solubilidade e a biodisponibilidade de certos medicamentos torna-os valiosos na melhoria da eficácia dos produtos farmacêuticos.                 

A proteína de ovo na dinâmica do mercado farmacêutico

Motoristas

• Estabilização e Emulsificação Eficazes de Proteínas de Ovo   

As proteínas do ovo são conhecidas pelas suas propriedades estabilizadoras e emulsionantes superiores, o que as torna altamente valiosas em aplicações farmacêuticas. Nas formulações de medicamentos, as proteínas do ovo funcionam como excelentes estabilizantes, mantendo a consistência e a qualidade do produto ao evitar a separação dos ingredientes. Servem também como emulsionantes eficazes, garantindo a dispersão uniforme de substâncias imiscíveis, como óleos e água. Esta capacidade é particularmente crucial em formulações complexas onde a consistência precisa é essencial para a eficácia. Ao melhorar a estabilidade e a homogeneidade dos produtos farmacêuticos, as proteínas do ovo contribuem para melhorar os sistemas de distribuição de medicamentos e o desempenho global do produto, impulsionando o crescimento do mercado.   

• Crescente procura por vacinas     

Egg proteins play a pivotal role in the manufacturing of various vaccines, including those for influenza and other viral infections, where they serve as a medium for the growth of vaccine antigens. The ability of egg proteins to support the cultivation of these antigens ensures the effectiveness and safety of the vaccines. As the global need for biologics continues to rise due to the prevalence of infectious diseases and the expansion of vaccination programs, egg proteins remain integral to the production process. This growing demand for biologics and vaccines thus drives the market for egg proteins. 

Opportunities

• Advancements in Pharmaceutical Technologies  

New technologies, such as targeted drug delivery systems and novel formulations, often require specialized stabilizers and emulsifiers to enhance their performance and effectiveness. Egg proteins, with their unique functional properties, are well-suited for these advanced applications. As pharmaceutical companies seek to develop more efficient and effective drug delivery solutions, the demand for egg proteins is expected to rise. Innovations in pharmaceutical technologies, including advanced drug delivery systems and formulations, have created significant opportunities for the use of egg proteins.    

• Rising Healthcare Expenditure    

With healthcare budgets expanding and spending on pharmaceuticals rising, there is a greater emphasis on developing high-quality and effective drug formulations. Egg proteins, known for their superior stabilizing and emulsifying properties, are increasingly being utilized to meet these demands. This rise in healthcare expenditure supports the investment in advanced pharmaceutical products and technologies, further driving the market for egg proteins. As healthcare priorities continue to evolve and expand, the role of egg proteins in ensuring the quality and efficacy of pharmaceutical products becomes increasingly prominent. The increasing global expenditure on healthcare and pharmaceuticals is creating growth opportunities for the egg protein market.    

Top of Form

Restraints/Challenges

• Availability of Alternative Proteins  

The availability of alternative proteins and stabilizers poses a challenge to the reliance on egg proteins in pharmaceuticals. With the growing interest in plant-based and synthetic alternatives, pharmaceutical companies have more options for stabilizers and emulsifiers that may offer similar or improved functionalities without the potential drawbacks associated with egg proteins. These alternatives can provide solutions for those with allergies or dietary restrictions and may be perceived as more sustainable or cost-effective. As the market for alternative ingredients expands, the demand for egg proteins may be affected, challenging the market growth.        

• Allergies to Egg Proteins

Allergies to egg proteins present a significant challenge in the widespread use of these proteins in pharmaceuticals. For individuals with egg allergies, exposure to egg proteins can trigger adverse reactions, which limits their suitability in drug formulations. This constraint necessitates careful consideration and labeling of pharmaceutical products to ensure the safety of consumers. The presence of egg proteins in medications must be managed to avoid allergic reactions, thereby impacting their broader adoption in the market. As a result, the prevalence of egg allergies can restrict the use of egg proteins, affecting their market potential and prompting the exploration of alternative ingredients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In June 2024, U.S. biotech company The EVERY Co. announced a partnership with Canada’s Landish Foods, a leader in nutritional wellness products in North America. Together, they are launching FERMY, a new range of ready-to-mix protein powders for beverages that feature egg white protein derived from precision fermentation
• In December 2023, ingredient innovator EVERY introduced its flagship product, EVERY Egg, the world's first liquid egg made without hens. Created through yeast fermentation, EVERY Egg was launched after nine years of product development by EVERY

Egg Protein in Pharmaceuticals Market Scope

The market is segmented on the basis of type, flavors, form, function, application, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Egg White Powder
• Egg Yolk Powder
• Whole Egg Protein

Flavors

• Flavoured
• Regular

Form

• Solid
• Liquid
• Powder

Function

• Binding
• Crystallization
• Emulsifying
• Leavening
• Preservatives
• Thickening

Application

• Bakery and Confectionery
• Dietary Supplements
• Feed
• Food and Beverages
• Ice Cream
• Meat Products
• Personal Care and Cosmetics
• Protein and Nutritional Bars

Distribution Channel

• Convenience Stores
• Medical and Drug Stores
• Online Store
• Supermarkets/Hypermarkets

Egg Protein in Pharmaceuticals Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, type, flavors, form, function, application, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the growing consumption of protein supplements and an increase in the production of egg protein. The high demand for protein-rich products, coupled with advancements in production technology and infrastructure, supports North America's market leadership. 

Asia-Pacific is expected to show significant growth due to the expanding presence of various market players and the rapid development of industrial capabilities in these countries. Increasing awareness of health and nutrition, coupled with rising disposable incomes, is driving demand for egg protein-based pharmaceuticals.

A secção do relatório sobre os países também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado que afetam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas, análise das cinco forças de Porter e estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas regionais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, o impacto das tarifas nacionais e as rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Análise da quota de mercado da proteína de ovo em produtos farmacêuticos

O cenário competitivo do mercado fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, presença regional, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produto, largura e amplitude do produto e domínio de aplicação . Os dados acima fornecidos estão apenas relacionados com o foco das empresas no mercado.

Alguns dos principais players de mercado que operam no mercado são:

• Eat Just, Inc.
• IntegriCulture Inc. (Japão)
• Aleph Farms (Israel)
• AVANTMEATS (China)
• Carnes de Crentes (EUA)
• newprotein (Argentina)
• (Israel)
• Meatable (Holanda)
• Mission Barns (EUA)
• BlueNalu (EUA)
• Simple Foods Inc. (EUA)
• Carnes Shiok (Singapura)
• CUBIQ FOODS SL (Espanha)

SKU-56731